Joint Institute of Metabolic Medicine between State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong and Jinan University, Guangzhou, China; State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, China; Department of Medicine, The University of Hong Kong, Hong Kong, China.
Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.
J Hepatol. 2016 Nov;65(5):988-997. doi: 10.1016/j.jhep.2016.05.041. Epub 2016 Jun 4.
BACKGROUND & AIMS: Inflammatory cell infiltration in the liver is a hallmark of non-alcoholic steatohepatitis (NASH). However, the pathological events which trigger the infiltration of inflammatory cells to mediate NASH pathogenesis remains poorly understood. This study aims to investigate the role of neutrophil-derived lipocalin 2 (LCN2) in mediating the transition from simple steatosis to NASH.
Animal models of NASH were induced by high fat high cholesterol (HFHC) diet and methionine- and choline-deficient (MCD) diet in LCN2 knockout mice and wild-type controls.
Circulating levels of LCN2 and its hepatic expression were markedly increased in both murine models and human subjects with NASH, and these changes were associated with increased infiltration of neutrophils. In diet-induced NASH models, hepatic injury, necroinflammation and infiltration of neutrophils and macrophages were substantially attenuated by genetic depletion of LCN2. In contrast, chronic infusion of recombinant LCN2 exacerbated diet-induced liver injury, inflammation and macrophage accumulation in a neutrophil-dependent manner. Primary mouse neutrophils lacking LCN2 exhibited a defective migration capacity, which can be reversed by replenishment with recombinant LCN2. Mechanistically, LCN2 induced the expression of the chemokine (C-X-C motif) receptor 2 (CXCR2), thereby leading to activation of ERK1/2 and production of proinflammatory chemokines. LCN2-induced inflammation, infiltration of macrophages and liver injury was abrogated in CXCR2-deficient mice.
These findings demonstrated that LCN2 acts as a central mediator to facilitate the crosstalk between neutrophils and hepatic macrophages via induction of the chemokine receptor CXCR2, thereby exacerbating steatohepatitis.
Lipocalin-2 levels in blood and the liver were markedly increased in both mouse models and human subjects with NASH, and these changes were associated with increased infiltration of neutrophils in the liver. In diet-induced NASH models, hepatic injury, necroinflammation and infiltration of neutrophils and macrophages were substantially attenuated by genetic depletion of lipocalin-2, but was augmented by chronic infusion of recombinant lipocalin-2. Lipocalin-2 induced the expression of the chemokine receptor CXCR2, thereby leading to activation of the mitogen-activated protein (MAP) kinase ERK1/2 and production of proinflammatory chemokines. Lipocalin-2-induced inflammation, infiltration of macrophages and liver injury was abrogated in CXCR2-deficient mice.
肝脏中的炎症细胞浸润是非酒精性脂肪性肝炎(NASH)的一个标志。然而,触发炎症细胞浸润以介导 NASH 发病机制的病理事件仍知之甚少。本研究旨在探讨中性粒细胞衍生的脂钙蛋白 2(LCN2)在介导单纯性脂肪变性向 NASH 转化中的作用。
在 LCN2 敲除小鼠和野生型对照中,用高脂肪高胆固醇(HFHC)饮食和蛋氨酸和胆碱缺乏(MCD)饮食诱导 NASH 动物模型。
在两种小鼠模型和 NASH 患者中,循环 LCN2 及其肝表达水平显著升高,这些变化与中性粒细胞浸润增加有关。在饮食诱导的 NASH 模型中,LCN2 的基因缺失可显著减轻肝损伤、坏死性炎症以及中性粒细胞和巨噬细胞的浸润。相反,重组 LCN2 的慢性输注以依赖中性粒细胞的方式加剧饮食诱导的肝损伤、炎症和巨噬细胞积聚。缺乏 LCN2 的原代小鼠中性粒细胞迁移能力受损,用重组 LCN2 补充可逆转这种情况。在机制上,LCN2 诱导趋化因子(C-X-C 基序)受体 2(CXCR2)的表达,从而导致 ERK1/2 的激活和促炎趋化因子的产生。在 CXCR2 缺陷型小鼠中,LCN2 诱导的炎症、巨噬细胞浸润和肝损伤被阻断。
这些发现表明,LCN2 作为一种中心介质,通过诱导趋化因子受体 CXCR2,促进中性粒细胞与肝巨噬细胞之间的串扰,从而加剧脂肪性肝炎。
在两种小鼠模型和 NASH 患者中,血液和肝脏中的脂钙蛋白 2 水平显著升高,这些变化与肝脏中中性粒细胞浸润增加有关。在饮食诱导的 NASH 模型中,LCN2 的基因缺失可显著减轻肝损伤、坏死性炎症以及中性粒细胞和巨噬细胞的浸润,但重组 LCN2 的慢性输注可加剧这种情况。LCN2 诱导趋化因子受体 CXCR2 的表达,从而导致丝裂原激活蛋白(MAP)激酶 ERK1/2 的激活和促炎趋化因子的产生。在 CXCR2 缺陷型小鼠中,LCN2 诱导的炎症、巨噬细胞浸润和肝损伤被阻断。